Nervgen Pharma NGEN
NASDAQ NGEN
$1.42 0.00 (-0.15%)
As of: Oct 23, 2026 · 3:56 PM EDT

Nervgen Pharma (NGEN) Other Investing Activities (2025 - 2026)

Updated

Analysis

Nervgen Pharma (NGEN) Other Investing Activities (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other investing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -127.00 Mn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 352.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -51.00 Mn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -22.00 Mn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 218.00 Mn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 174.00 Mn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -56.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 20.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -1.00 Mn
10 Nervgen Pharma 102.71 Mn 1.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6,133.35
Jun 30, 2025 18,209.53
Mar 31, 2025 17,584.60
API Access

Nervgen Pharma Other Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-investing-activities&ticker=NGEN&period=max&api_key=YOUR_API_KEY